Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.

Cell Death & Differentiation

21 janvier 2014
Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists.

Yamazaki T, Hannani D, Poirier-Colame V, Ladoire S, Locher C, Sistigu A, Prada N, Adjemian S, Catani JP, Freudenberg M, Galanos C, André F, Kroemer G, Zitvogel L.